Refractory Cancer Pain and Intrathecal Therapy: Critical Review of a Systematic Review-Reference-Cited by-同舟云学术

Refractory Cancer Pain and Intrathecal Therapy: Critical Review of a Systematic Review

Published:2023-04-13 Issue:3 Volume:12 Page:645-654
ISSN:2193-8237
Container-title:Pain and Therapy
language:en
Short-container-title:Pain Ther

Author:

Mercadante Sebastiano^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40122-023-00507-z.pdf

Reference37 articles.

1. Mercadante S. Cancer pain treatment strategies in patients with cancer. Drugs. 2022;82:1357–66.

2. Afsharimani B, Kindl K, Good P, Hardy J. Pharmacological options for the management of refractory cancer pain—what is the evidence? Support Care Cancer. 2015;23:1473–8.

3. Deer TR, Caraway DL, Wallace MS. A definition of refractory pain to help determine suitability for device implantation. Neuromodulation. 2014;17:711–5.

4. Duarte R, Copley S, Nevitt S, Maden M, Al-Ali AM, Dupoiron D, Eldabe S. Effectiveness and safety of intrathecal drug delivery systems for the management of cancer pain: a systematic review and meta-analysis. Neuromodulation. 2022;S1094–7159(22):00563–73.

5. Denis D, Duarte Rui, Carvajal G, Aubrun F, Eldabe S. Rationale and recent advances in targeted drug delivery for cancer pain: is it time to change the paradigm? Pain Physician. 2022; 25:E414–E425

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventional procedures in an acute palliative care unit: clinical audit;BMJ Supportive & Palliative Care;2023-12-13

2. The Need of a Comprehensive Approach in a Condition of Poorly Opioid-Responsive Cancer Pain;Journal of Pain and Symptom Management;2023-11